N/A
Completed N=494
Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke
Stroke, Acute
Source: ClinicalTrials.gov NCT03411642 ↗
Enrolled (actual)
494
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Number of Participants With Diagnostic Findings That Lead to a Change in Acute Treatment or Treatment for Secondary Prevention — 64; 390; 86; 368 Participants
Summary
The Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke (CONTEST) aims at assessing the diagnostic value of transesophageal echocardiography (TEE) and transthoracic echocardiography (TTE) with regards to treatment consequences in patients with acute ischemic stroke.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Diagnostic Findings That Lead to a Change in Acute Treatment or Treatment for Secondary Prevention |
64; 390; 86; 368 | — |
| SECONDARY Number of Patients With Change of Assessment of Stroke Etiology After TEE |
52; 401; 1 | — |
Eligibility Criteria
Inclusion Criteria
- acute ischemic stroke or transitory ischemic attack (TIA)
- age ≥18 years
- informed consent
Exclusion Criteria
- Patients with already defined stroke etiology and determined secondary prevention treatment strategy prior to echocardiography (e.g. atrial fibrillation, carotid artery stenosis, cervical artery dissection)
Data sourced from ClinicalTrials.gov (NCT03411642). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.